Vigil, B. (2020). Characterizing a Novel Engineered Therapeutic Agent to Reverse Lupus Symptoms. URJ-UCCS: Undergraduate Research Journal at UCCS, 13(2). Retrieved from https://urj.uccs.edu/index.php/urj/article/view/511